Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin sensitisation, other
Remarks:
in vivo test already available
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: well-documented GLP study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1992
Report date:
1992

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
EPA OTS 798.4100 (Skin Sensitisation)
GLP compliance:
yes (incl. QA statement)
Remarks:
testing lab.
Type of study:
guinea pig maximisation test

Test material

Constituent 1
Chemical structure
Reference substance name:
4'-hydroxyacetophenone
EC Number:
202-802-8
EC Name:
4'-hydroxyacetophenone
Cas Number:
99-93-4
Molecular formula:
C8H8O2
IUPAC Name:
1-(4-hydroxyphenyl)ethan-1-one
Details on test material:
Name of the test substance used in the study report: C-01650 (4-HAP)

In vivo test system

Test animals

Species:
guinea pig
Strain:
Hartley
Sex:
male
Details on test animals and environmental conditions:
Weight at study initiation: 300-500 grams, at time of dosing
Acclimation period: at least 7 days
Animal identification: Each animal was assigned an unique and individual number. This number was permanently indicated on the animal with a tar tag.
They were housed individually in stainless steel, wire mesh bottom cages (temperature: 64 - 79°F, humidity: 40 - 70%, light/dark rhythm: 12/12).
Fresh guinea Pig feed was provided ad libitium throughout both the acclimation and study periods; water was provided ad libitum.

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal
Vehicle:
other: propylene glycol
Concentration / amount:
Intradermal range finding phase: 5, 4, 2 and 1% of the test article
Topical range finding phase: 75, 50, 25 and 10% of the test article
Challenge: 0.5 g of a 75% mixture
Challengeopen allclose all
Route:
intradermal
Vehicle:
other: propylene glycol
Concentration / amount:
Intradermal range finding phase: 5, 4, 2 and 1% of the test article
Topical range finding phase: 75, 50, 25 and 10% of the test article
Challenge: 0.5 g of a 75% mixture
No. of animals per dose:
total: 50
Details on study design:
Intradermal injection (as a 5% solution in propylene glycol with and without Freund's adjuvant) and then by topical application (5% in propylene glycol) eight days later.
Two weeks after the second induction, animals were challenged with 0.5 g of test material as a 75% preparation in petrolatum using a 24-h dermal exposure.
Intradermal Range Finding Study: Four w/v dilutions of the test artiele were prepared in propylene glycol and administered to each of five guines pigs. The dilutions used were 5%, 4%, 2%, and 1 %. Each dilution was intradermally injected at a volume of 0.1 ml. Two injections on each side of the dorsal midline were made above the scapular region.
Approximately 24 and 48 hours after dosing, all sites were scored for erythema and edema according to the Draize scoring.
Topical Range Finding Study: Four w/w dilutions of the test article were prepared in petrolatum and administered to each of five guinea pigs. The concentrations used were: 75%, 50%, 25%, and 10%. A dose of 0.5 gram of each concentration of the test article was applied to a one square inch gauze patch which was then placed on the skin of the flank region. Two patches wert placed on each side of the dorsal midline. The patches were taped in place and the trunk of the animal was wrapped with a non-reactive, occlusive wrapping.
Approximately 24 hours following patch application, all wrappings were removed and the skin wiped to remove any remaining lest article.
Approximately 24 and 48 hours after patch removal, all sites were scored for erythema and edema according to the Draize scoring method. From these readings, the highest non-irritating dose level was selected for the challenge phase of the study.
Positive control substance(s):
yes

Results and discussion

In vivo (non-LLNA)

Results
Reading:
other: challenge
Hours after challenge:
24
Group:
test chemical
Dose level:
75% of a mixture
No. with + reactions:
0
Total no. in group:
20
Remarks on result:
other: Reading: other: challenge. . Hours after challenge: 24.0. Group: test group. Dose level: 75% of a mixture. No with. + reactions: 0.0. Total no. in groups: 20.0.

Applicant's summary and conclusion

Interpretation of results:
not sensitising
Remarks:
Migrated information
Conclusions:
Under the conditions of this test, 4-HAP, CAS# 99-93-4) is considered to be a non-sensitizer (0% sensitized) and the positive control, DNCB, is considered to be an extreme sensitizer (100% sensitized).